PURPOSE: In children the assessment of solid tumors' response to chemotherapy is based primarily on size reduction, which can be unreliable and a late marker, in the presence of necrosis. We aimed to establish whether apparent diffusion coefficient (ADC) values of childhood neuroblastomas show proportional changes in relation to chemotherapy response. METHODS: We evaluated 15 pediatric patients with abdominopelvic neuroblastomas, who had undergone MRI before and after chemotherapy. Two radiologists retrospectively analyzed all images by drawing a round uniform region-of-interest in the solid/contrast-enhancing portion of the lesions in consensus. The ADC values from pre- and postchemotherapy images were compared. RESULTS: Postchemotherapy ADC values were significantly higher than those obtained before treatment (P < 0.05, for minimum, maximum, and median ADC values). CONCLUSION: Our results support diffusion-weighted MRI as a promising noninvasive biomarker of therapeutic responses. To the best of our knowledge, this is the first report to compare diffusion- weighted imaging findings before and after chemotherapy in childhood neuroblastic tumors.
PURPOSE: In children the assessment of solid tumors' response to chemotherapy is based primarily on size reduction, which can be unreliable and a late marker, in the presence of necrosis. We aimed to establish whether apparent diffusion coefficient (ADC) values of childhood neuroblastomas show proportional changes in relation to chemotherapy response. METHODS: We evaluated 15 pediatric patients with abdominopelvic neuroblastomas, who had undergone MRI before and after chemotherapy. Two radiologists retrospectively analyzed all images by drawing a round uniform region-of-interest in the solid/contrast-enhancing portion of the lesions in consensus. The ADC values from pre- and postchemotherapy images were compared. RESULTS: Postchemotherapy ADC values were significantly higher than those obtained before treatment (P < 0.05, for minimum, maximum, and median ADC values). CONCLUSION: Our results support diffusion-weighted MRI as a promising noninvasive biomarker of therapeutic responses. To the best of our knowledge, this is the first report to compare diffusion- weighted imaging findings before and after chemotherapy in childhood neuroblastic tumors.
Authors: Barış Türkbey; Ömer Aras; Nevzat Karabulut; Ahmet Tuncay Turgut; Erhan Akpinar; Sedat Alibek; Yuxi Pang; Şükrü Mehmet Ertürk; Riham H El Khouli; David A Bluemke; Peter L Choyke Journal: Diagn Interv Radiol Date: 2011-09-19 Impact factor: 2.630
Authors: Øystein E Olsen; Annmarie C Jeanes; Neil J Sebire; Derek J Roebuck; Anthony J Michalski; Rupert A Risdon; Catherine M Owens Journal: Eur Radiol Date: 2004-02-11 Impact factor: 5.315
Authors: Brian D Ross; Bradford A Moffat; Theodore S Lawrence; Suresh K Mukherji; Stephen S Gebarski; Douglas J Quint; Timothy D Johnson; Larry Junck; Patricia L Robertson; Karin M Muraszko; Qian Dong; Charles R Meyer; Peyton H Bland; Patrick McConville; Hairong Geng; Alnawaz Rehemtulla; Thomas L Chenevert Journal: Mol Cancer Ther Date: 2003-06 Impact factor: 6.261
Authors: Halil Ibrahim Serin; Sureyya Burcu Gorkem; Selim Doganay; Saliha Cıracı; Ekrem Unal; Mahmut Guzel; Ahmet Kucuk; Ali Kurtsoy; Abdulhakim Coskun Journal: Jpn J Radiol Date: 2016-07-14 Impact factor: 2.374
Authors: Lucy A Fowkes; Dow-Mu Koh; David J Collins; Neil P Jerome; David MacVicar; Sue C Chua; Andrew D J Pearson Journal: Pediatr Radiol Date: 2015-06-05
Authors: Laura Privitera; Patrick W Hales; Layla Musleh; Elizabeth Morris; Natalie Sizer; Giuseppe Barone; Paul Humphries; Kate Cross; Lorenzo Biassoni; Stefano Giuliani Journal: J Magn Reson Imaging Date: 2020-12-06 Impact factor: 5.119